In 2018, three back-to-back publications unraveled the role of the gut microbiota—a rich organ within the gastrointestinal tract primarily composed of 10 13 commensal bacteria—in modulating ICI ...

The choice of frontline therapy for a patient with chronic phase chronic myeloid leukemia (CP-CML) can have a profound effect on the long-term clinical outcome. Currently, five tyrosine kinase ...

A cross-sectional survey was conducted at a tertiary academic pediatric center in Toronto, Canada. English-speaking pediatric patients with cancer age 12 years and older, as well as their caregivers, ...

Establishing the Philippine Cancer Center National Cancer Research Agenda 2024-2028: Insights and Future Directions Health care in Jordan is relatively advanced, with a mix of public and private ...

Empowering the Next Generation of Cancer Research Advocates: Community Engagement Across the Research Continuum Multicancer early detection tests (MCEDs), sometimes referred to as liquid biopsies, are ...

The global discourse surrounding ENDS has generated insightful perspectives, but these may not fully align with the realities of LMICs still battling higher (than global average) tobacco use rates.

Which Is the Best Tyrosine Kinase Inhibitor for Newly Diagnosed Chronic Myelogenous Leukemia? Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with ...

Erratum: Utility of Whole-Body Magnetic Resonance Imaging Surveillance in Children and Adults With Cancer Predisposition Syndromes: A Retrospective Study ...

Toward Functional Biomarkers of Response to Neoadjuvant Oncolytic Virus in Stage II Melanoma: Immune-Förster Resonance Energy Transfer and the Dynamic Tumor Immune Microenvironment This ...

Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials ...